Literature DB >> 3191488

Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.

K M Mulder1, M K Ramey, N M Hoosein, A E Levine, X H Hinshaw, D E Brattain, M G Brattain.   

Abstract

Previous work indicated that transforming growth factor-beta (TGF-beta) elicits proliferation-inhibitory effects in the human colon carcinoma cell line MOSER. This paper describes the isolation and characterization of spontaneously arising subclones from this TGF-beta-sensitive parental line which were relatively refractory to the inhibitory effects of TGF-beta. While the parental cell line responded to TGF-beta with an inhibition of cellular proliferation in monolayer culture and in soft agarose, an increase in extracellular fibronectin, and a down-regulation of c-myc protooncogene expression, these responses were absent or attenuated in the sublines. However, the resistant clones retained the ability to specifically bind TGF-beta. N,N-Dimethylformamide and retinoic acid, two other agents associated with induction of a partial differentiation-like response in the MOSER parental cells (similar to that elicited by TGF-beta), inhibited the monolayer proliferation of both the parental cells and the TGF-beta-resistant sublines. Thus, the refractoriness observed in the isolated clones was relatively specific for TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191488

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells.

Authors:  W C Duivenvoorden; H W Hirte; G Singh
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

2.  Regulation of transforming growth factor expression in rat intestinal epithelial cell lines.

Authors:  S Suemori; C Ciacci; D K Podolsky
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.

Authors:  T A McCaffrey; S Consigli; B Du; D J Falcone; T A Sanborn; A M Spokojny; H L Bush
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase.

Authors:  Nageswara R Pulipati; Qunyan Jin; Xin Liu; Baodong Sun; Manoj K Pandey; Jonathan P Huber; Wei Ding; Kathleen M Mulder
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

5.  Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.

Authors:  J A Pietenpol; J T Holt; R W Stein; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 6.  Transforming growth factor-beta and prostate cancer.

Authors:  M S Steiner
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 7.  The role of fibroblasts in tumor behavior.

Authors:  M Grégoire; B Lieubeau
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

8.  Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue.

Authors:  Dionisios Mitropoulos; Aspasia Kiroudi; Evangelia Christelli; Efraim Serafetinidis; Anastasios Zervas; Ioannis Anastasiou; Constantinos Dimopoulos
Journal:  Urol Res       Date:  2004-09-07

9.  Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype.

Authors:  S L MacKay; T Auffenberg; C L Tannahill; R Ksontini; M D Josephs; M Nowak; L L Moldawer; E M Copeland
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

10.  Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha.

Authors:  H Lahm; L Suardet; P L Laurent; J R Fischer; A Ceyhan; J C Givel; N Odartchenko
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.